Last reviewed · How we verify
NCT04595396
Laparoscopic Gastric Bypass as Metabolic Surgery in Obesity Class 1
trial testing Laparoscopic Gastric Bypass in Type2 Diabetes in 51 participants. Completed in 31 December 2019.
1 January 2019
Quick facts
| Lead sponsor | CARLOS ZERRWECK LOPEZ |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 51 |
| Start date | 1 September 2012 |
| Primary completion | 1 January 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Laparoscopic Gastric Bypass
Conditions studied
- Type2 Diabetes — all drugs for Type2 Diabetes →
- Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →
- Laparoscopic Gastric Bypass — all drugs for Laparoscopic Gastric Bypass →
- Obesity — all drugs for Obesity →
Sponsor
CARLOS ZERRWECK LOPEZ
Who can join
Adults 18 to 60, any sex, with Type2 Diabetes or Bariatric Surgery Candidate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective study including Mexican patients diagnosed with type 2 diabetes and class 1 obesity, undergoing laparoscopic gastric bypass. The objective was to determine short, mid-and long-term outcomes (weight loss, metabolic, morbidity and diabetes remission). A subanalysis was included, based on preoperative usage of one (Group A) or more antidiabetics ± insulin (Group B).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Metabolic Surgery and Class 1 Obesity (< 35 kg/m<sup>2</sup>): a Prospective Study with Short-, Mid-, and Long-term Results Among Latinos.
Cevallos L, Rodríguez FM, Herrera A, Sepúlveda EM, et al · · 2021 · cited 5× · PMID 33598844 · DOI 10.1007/s11695-021-05275-3
Verify or expand the search:
- PubMed search for NCT04595396
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Type2 Diabetes
Currently open trials in the same condition.
- NCT05277558 — Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) · recruiting
- NCT05015283 — Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission · NA · recruiting
- NCT05006508 — Prevention With the Health and Lifestyle Tool · NA · active not recruiting
- NCT04717050 — Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity · NA · active not recruiting
- NCT05220917 — Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04595396 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CARLOS ZERRWECK LOPEZ
- Last refreshed: 20 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04595396.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing